Protara Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Protara Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
  • Protara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$9.51M, a 15.8% increase year-over-year.
  • Protara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$40.7M, a 39.3% increase year-over-year.
  • Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$40.4M, a 38.7% increase from 2022.
  • Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$66M, a 39.6% decline from 2021.
  • Protara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$47.3M, a 39.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$40.4M +$25.5M +38.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$66M -$18.7M -39.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$47.3M -$13.3M -39.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 -$34M -$26.1M -334% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$7.83M +$12.9M +62.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$20.7M +$9.24M +30.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 -$30M -$1.44M -5.04% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 -$28.5M -$7.15M -33.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 -$21.4M -$18M -540% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$3.34M +$4.57M +57.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$7.91M +$58K +0.73% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$7.97M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.